De Lena, M <br/><br/>
CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 1995 
 - 953-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1995.13.4.953  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Chi-Square Distribution<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Karnofsky Performance Status<br/>L-Lactate Dehydrogenase--blood<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Pilot Projects<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Remission Induction<br/>Survival Rate<br/>Treatment Failure<br/>Vincristine--administration & dosage